DE60142913D1 - Arzneilösungen enthaltend modafinilverbindungen - Google Patents
Arzneilösungen enthaltend modafinilverbindungenInfo
- Publication number
- DE60142913D1 DE60142913D1 DE60142913T DE60142913T DE60142913D1 DE 60142913 D1 DE60142913 D1 DE 60142913D1 DE 60142913 T DE60142913 T DE 60142913T DE 60142913 T DE60142913 T DE 60142913T DE 60142913 D1 DE60142913 D1 DE 60142913D1
- Authority
- DE
- Germany
- Prior art keywords
- modafinil compounds
- drug solutions
- solutions contain
- contain modafinil
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- YFGHCGITMMYXAQ-UHFFFAOYSA-N 2-[(diphenylmethyl)sulfinyl]acetamide Chemical class C=1C=CC=CC=1C(S(=O)CC(=O)N)C1=CC=CC=C1 YFGHCGITMMYXAQ-UHFFFAOYSA-N 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23948800P | 2000-10-11 | 2000-10-11 | |
| US09/974,473 US6489363B2 (en) | 2000-10-11 | 2001-10-10 | Pharmaceutical solutions of modafinil compounds |
| PCT/US2001/031685 WO2002030413A1 (en) | 2000-10-11 | 2001-10-11 | Pharmaceutical solutions of modafinil compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60142913D1 true DE60142913D1 (de) | 2010-10-07 |
Family
ID=26932612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60142913T Expired - Lifetime DE60142913D1 (de) | 2000-10-11 | 2001-10-11 | Arzneilösungen enthaltend modafinilverbindungen |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6489363B2 (de) |
| EP (1) | EP1324755B1 (de) |
| JP (1) | JP2004510816A (de) |
| KR (1) | KR100846914B1 (de) |
| CN (1) | CN100518726C (de) |
| AT (1) | ATE478662T1 (de) |
| AU (2) | AU2001296785B2 (de) |
| BG (1) | BG66221B1 (de) |
| BR (1) | BR0114813A (de) |
| CA (1) | CA2425218C (de) |
| CZ (1) | CZ2003966A3 (de) |
| DE (1) | DE60142913D1 (de) |
| EA (1) | EA005572B1 (de) |
| HK (1) | HK1057336A1 (de) |
| HU (1) | HU229424B1 (de) |
| IL (2) | IL155263A0 (de) |
| MX (1) | MXPA03003150A (de) |
| NO (1) | NO333096B1 (de) |
| NZ (1) | NZ525166A (de) |
| PL (1) | PL214879B1 (de) |
| SK (1) | SK287436B6 (de) |
| WO (1) | WO2002030413A1 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA03003152A (es) * | 2000-10-11 | 2005-07-29 | Cephalon Inc | Composiciones que contienen compuestos de modafinilo. |
| US6919378B2 (en) * | 2000-10-11 | 2005-07-19 | Cephalon, Inc. | Pharmaceutical solutions of modafinil compounds |
| US6992219B2 (en) * | 2002-08-09 | 2006-01-31 | Cephalon France | Modafinil polymorphic forms |
| US20040116532A1 (en) | 2002-09-13 | 2004-06-17 | Craig Heacock | Pharmaceutical formulations of modafinil |
| FR2849029B1 (fr) * | 2002-12-20 | 2005-03-18 | Lafon Labor | Procede de preparation et formes cristallines des enantiomeres optiques du modafinil. |
| CA2519117C (en) * | 2003-03-17 | 2010-03-02 | Neurohealing Pharmaceuticals, Inc. | High potency dopaminergic treatment of neurological impairment associated with brain injury |
| US20040253308A1 (en) * | 2003-04-29 | 2004-12-16 | Barr Laboratories, Inc. | Surface-treated modafinil particles |
| US8153159B2 (en) * | 2003-09-18 | 2012-04-10 | Cephalon, Inc. | Modafinil modified release pharmaceutical compositions |
| US7368591B2 (en) | 2003-09-19 | 2008-05-06 | Cephalon France | Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation |
| US20060024370A1 (en) * | 2004-07-29 | 2006-02-02 | Cephalon France | Modafinil oral lyophilizate |
| BRPI0500520A (pt) * | 2005-02-16 | 2006-09-26 | Henry Jun Suzuki | uso de agentes flavorizantes aromáticos de alto ponto de fusão como agentes solubilizantes ou inibidores de cristalização em composições farmacêuticas |
| CA2614777C (en) * | 2005-07-21 | 2012-04-17 | Neurohealing Pharmaceuticals, Inc. | Rapid onset and short term modafinil compositions and methods of use thereof |
| US7884135B2 (en) * | 2006-08-14 | 2011-02-08 | Neurohealing Pharmaceuticals, Inc. | Modafinil-based treatment for premature ejaculation |
| US8173169B2 (en) * | 2007-07-11 | 2012-05-08 | Hikma Pharmaceuticals | Formulation and process for the preparation of modafinil |
| CA2629979A1 (en) * | 2008-04-25 | 2009-10-25 | Pharmascience Inc. | Novel resveratrol compositions |
| FR2987266B1 (fr) | 2012-02-28 | 2014-12-19 | Debregeas Et Associes Pharma | Procede d'obtention d'une composition pharmaceutique a base de modafinil, composition pharmaceutique ainsi obtenue et son application |
| FR2987265B1 (fr) | 2012-02-28 | 2014-02-28 | Debregeas Et Associes Pharma | Composition pharmaceutique sous forme de sirop a base de modafinil, son procede de fabrication et son application |
| CN104853752B (zh) * | 2012-10-18 | 2018-10-23 | 艾伯维公司 | 嘧啶二酮衍生物化合物的制剂 |
| US9616068B2 (en) | 2014-10-27 | 2017-04-11 | Pohela LLC | Animal training using cognitive enhancement |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1584462A (en) | 1977-03-31 | 1981-02-11 | Lafon Labor | N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them |
| FR2593809B1 (fr) | 1986-01-31 | 1988-07-22 | Lafon Labor | Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique |
| FR2663225B1 (fr) | 1990-06-14 | 1994-11-04 | Lafon Labor | Nouvelle utilisation du modafinil. |
| US5618845A (en) | 1994-10-06 | 1997-04-08 | Cephalon, Inc. | Acetamide derivative having defined particle size |
| FR2771004B1 (fr) | 1997-11-19 | 2000-02-18 | Inst Curie | Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse |
| US6200968B1 (en) | 1998-08-06 | 2001-03-13 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
| US20010034373A1 (en) | 2000-02-09 | 2001-10-25 | Matthew Miller | Low dose modafinil for enhancement of cognitive function |
-
2001
- 2001-10-10 US US09/974,473 patent/US6489363B2/en not_active Expired - Lifetime
- 2001-10-11 CA CA2425218A patent/CA2425218C/en not_active Expired - Fee Related
- 2001-10-11 WO PCT/US2001/031685 patent/WO2002030413A1/en active Application Filing
- 2001-10-11 AU AU2001296785A patent/AU2001296785B2/en not_active Ceased
- 2001-10-11 KR KR1020037005057A patent/KR100846914B1/ko not_active IP Right Cessation
- 2001-10-11 EP EP01977685A patent/EP1324755B1/de not_active Expired - Lifetime
- 2001-10-11 JP JP2002533856A patent/JP2004510816A/ja active Pending
- 2001-10-11 MX MXPA03003150A patent/MXPA03003150A/es active IP Right Grant
- 2001-10-11 DE DE60142913T patent/DE60142913D1/de not_active Expired - Lifetime
- 2001-10-11 IL IL15526301A patent/IL155263A0/xx active IP Right Review Request
- 2001-10-11 PL PL361134A patent/PL214879B1/pl unknown
- 2001-10-11 AT AT01977685T patent/ATE478662T1/de not_active IP Right Cessation
- 2001-10-11 NZ NZ525166A patent/NZ525166A/en not_active IP Right Cessation
- 2001-10-11 EA EA200300450A patent/EA005572B1/ru not_active IP Right Cessation
- 2001-10-11 HU HU0302478A patent/HU229424B1/hu not_active IP Right Cessation
- 2001-10-11 BR BR0114813-3A patent/BR0114813A/pt active Search and Examination
- 2001-10-11 AU AU9678501A patent/AU9678501A/xx active Pending
- 2001-10-11 CZ CZ2003966A patent/CZ2003966A3/cs unknown
- 2001-10-11 CN CNB018171273A patent/CN100518726C/zh not_active Expired - Fee Related
- 2001-10-11 SK SK440-2003A patent/SK287436B6/sk not_active IP Right Cessation
-
2003
- 2003-04-06 IL IL155263A patent/IL155263A/en not_active IP Right Cessation
- 2003-04-10 NO NO20031648A patent/NO333096B1/no not_active IP Right Cessation
- 2003-04-14 BG BG107720A patent/BG66221B1/bg unknown
-
2004
- 2004-01-09 HK HK04100157.5A patent/HK1057336A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60142913D1 (de) | Arzneilösungen enthaltend modafinilverbindungen | |
| HK1079446A1 (en) | Pharmeceutical solid dispersions of modafinil compounds | |
| NO20053920D0 (no) | Preparat for og behandling av demyelineringssykdommer og paralyse ved administrering av remyelineringsmidler. | |
| SE0100901D0 (sv) | New composition | |
| ATE512163T1 (de) | Verabreichung von mitteln zur behandlung von entzündungen | |
| UY27175A1 (es) | Nueva sal succinato de o-desmetil- venlafaxina | |
| BR0313747A (pt) | Inibidores de transcriptase reversa de não-nucleosìdeo | |
| DE60313597D1 (de) | Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis | |
| ATE461217T1 (de) | Glp-1-verbindungen | |
| AR027355A1 (es) | Acidos tiazolidincarboxilicos | |
| DK1781277T3 (da) | Kombinationssammensætning, der omfatter Ibuprofen og Paracetamol | |
| ATE350377T1 (de) | Substituierte 3-pyrrolidin-indol-derivate | |
| PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
| WO2003066597A3 (en) | Guanidino compounds | |
| NO20043792L (no) | New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine | |
| SE0003476D0 (sv) | Compounds | |
| NO20051261L (no) | Morfin-6-glukuronidsalt | |
| CY1105165T1 (el) | Φαρμακευτικη συνθεση που πepιλαμβανει συνδυασμο μετφορμινης και 4-οξοβουτανικου οξεος και η χρηση αυτης για τη θepαπεια του διαβητη | |
| HUP0200152A2 (hu) | KQT1 csatornák gátlóinak alkalmazása parazita férgek és ektoparaziták által okozott betegségek kezelésére alkalmas gyógyszerkészítmények előállítására | |
| DE60137069D1 (de) | Arzneizusammensetzungen enthaltend modafinilverbindungen | |
| SE0001916D0 (sv) | Novel formulation | |
| SE0000303D0 (sv) | Novel compounds | |
| DE60003074D1 (de) | Fusidinsäure-derivate | |
| SE0300535D0 (sv) | Treatment of burns | |
| EA200500538A1 (ru) | Фармацевтическое средство для эндоназального применения при лечении болезней и нарушений нервной системы |